Eloxx Pharmaceuticals, Inc. (ELOX)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary NASDAQ $
12. 11
+0.17
+1.4238%
$
90.42M Market Cap
- P/E Ratio
- Div Yield
238,585 Volume
0 Eps
$ 11.94
Previous Close 
Want to track ELOX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eloxx Pharmaceuticals, Inc. (ELOX) Statistics
Valuation metrics
Market Cap 90.42M
Enterprise value 84.06M
Trailing P/E (ttm) -2.05
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) -6.9
Enterprise Value/Revenue -
Enterprise Value/EBITDA -16.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 93.1K
Average volume (90 days) 33.05K
Price summary
52-Week low 0
52-Week high 17.5
Beta -
50-Day moving average 11.97
200-Day moving average 2.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:11
Last split Date 1 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.64%
Return on equity 0.72%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.45
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.48%
Book value per share (mrq) -1.73
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
